Search

everythinglearnresearchcommunity

for

Search:↓

GERD symptoms are linked to acid exposure time and daytime sleepiness, influenced by ghrelin levels.

New treatment effectively reverses hair thinning in most patients with mild side effects.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

Natesto nasal gel improves erectile function and mood in men with low testosterone within 30 days.

Inhibiting retinoic acid activates WNT signaling, potentially aiding hair disorder and skin cancer treatments.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Ashwagandha root improved symptoms of nonclassic 11-hydroxylase deficiency in an elderly woman.

Minoxidil effectively treats severe hypertension but has notable side effects.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

High-dose androgen therapy can help manage certain types of androgen resistance.

New treatments for male hypogonadism are easier to use and target specific tissues to reduce side effects.

Strong skin creams work well for long-term scalp inflammation in Rapp-Hodgkin Ectodermal Dysplasia.

Upadacitinib effectively treats pyoderma gangrenosum.

Minoxidil effectively lowers blood pressure and initially increases plasma renin activity without raising aldosterone levels.

Plant extracts effectively reduce hair loss and increase growth, offering a safe alternative treatment.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Brimonidine is effective for reducing facial redness in skin conditions and has potential for broader dermatological uses.

Using growth factor injections and minoxidil together can significantly improve hair growth in people with hair loss.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Naringenin and its combination with minoxidil significantly improved hair growth in mice.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

Smart microneedles improve hair loss treatment by delivering drugs precisely with fewer side effects.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

CRH causes hair loss by reducing cell survival in hair follicles.

Low-dose naltrexone may help reduce redness in certain scalp conditions.

Double-stranded RNA helps regenerate hair follicles by increasing retinoic acid production and signaling.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.